Finance

Lists
196170:KOSDAQ
Alteogen Inc
â‚©288,500.00
+1.94%
(+5,500.00) 1D
Sep 4, 3:30:20 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 196170...
Open
â‚©290,500
High
â‚©294,000
Low
â‚©284,250
Mkt. cap
20.10T
Avg. vol.
634.88K
Volume
613.86K
Dividend
0.10%
Quarterly dividend
â‚©71
Ex-dividend date
Dec 29, 2025
P/E ratio
118.05
52-wk high
â‚©437,692
52-wk low
â‚©194,615
EPS
â‚©2,444
Shares outstanding
69.66M
No. of employees
181
Open
â‚©290,500
High
â‚©294,000
Low
â‚©284,250
Mkt. cap
20.10T
Avg. vol.
634.88K
Volume
613.86K
Dividend
0.10%
Quarterly dividend
â‚©71
Ex-dividend date
Dec 29, 2025
P/E ratio
118.05
52-wk high
â‚©437,692
52-wk low
â‚©194,615
EPS
â‚©2,444
Shares outstanding
69.66M
No. of employees
181
News stories
From web sources and news partners
About Alteogen Inc
CEOSoon Jae Park
Employees181
Founded2008
Headquarters-
SectorBiotechnology
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
49.01B
64.51B
71.60B
68.89B
Cost of goods sold
9.16B
21.94B
10.07B
7.40B
Cost of revenue
9.16B
21.94B
10.07B
7.40B
Research and development expenses
7.96B
14.91B
15.39B
20.74B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.24B
5.56B
6.49B
5.81B
Operating expense
13.18B
22.93B
22.22B
27.31B
Total operating expenses
22.34B
44.87B
32.30B
34.71B
Operating income
26.67B
19.64B
39.30B
34.18B
Other non operating income
-8.96M
46.64B
32.47B
-7.88B
EBT including unusual items
30.36B
69.27B
83.68B
32.75B
EBT excluding unusual items
30.44B
68.48B
83.74B
31.07B
Income tax expense
8.33B
-5.16B
12.34B
2.76B
Effective tax rate
27.45%
-7.45%
14.75%
8.43%
Other operating expenses
104.90M
177.84M
82.10M
449.66M
Net income
22.34B
69.24B
71.70B
28.42B
Net profit margin
45.59%
107.33%
100.14%
41.25%
Earnings per share
194.62
996.92
702.31
531.00
Interest and investment income
3.02B
3.34B
3.46B
3.60B
Interest expense
-3.07B
-3.49B
-3.11B
-3.95B
Net interest expenses
-50.71M
-150.77M
352.60M
-344.05M
Depreciation and amortization charges
195.01M
174.74M
204.36M
215.42M
EBITDA
28.03B
22.44B
42.20B
37.08B
Gain or loss from assets sale
248.55K
14.00K
14.00M
-14.00M
AI content may include mistakes. Learn more
Google apps